EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 36 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $283,000 | +36.7% | 27,637 | +41.9% | 0.01% | +75.0% |
| Q2 2019 | $207,000 | -11.9% | 19,482 | +15.8% | 0.00% | -20.0% |
| Q1 2019 | $235,000 | -78.5% | 16,830 | -84.3% | 0.01% | -82.1% |
| Q4 2018 | $1,092,000 | -32.4% | 107,441 | -19.1% | 0.03% | -17.6% |
| Q3 2018 | $1,615,000 | +6.2% | 132,754 | +6.0% | 0.03% | +17.2% |
| Q2 2018 | $1,521,000 | +482.8% | 125,218 | +583.9% | 0.03% | +383.3% |
| Q4 2017 | $261,000 | +77.6% | 18,309 | +34.7% | 0.01% | +100.0% |
| Q3 2017 | $147,000 | – | 13,597 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,787,091 | $20,462,000 | 6.02% |
| INTERWEST VENTURE MANAGEMENT CO | 1,599,592 | $18,315,000 | 3.89% |
| NEXTHERA CAPITAL LP | 263,600 | $3,018,000 | 1.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 385,301 | $4,412,000 | 0.86% |
| RA Capital Management | 354,200 | $4,056,000 | 0.50% |
| DAFNA Capital Management LLC | 35,977 | $412,000 | 0.35% |
| Boxer Capital, LLC | 138,331 | $1,584,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 238,907 | $2,735,000 | 0.15% |
| Monashee Investment Management LLC | 31,500 | $361,000 | 0.14% |
| Lombard Odier Asset Management (USA) Corp | 100,000 | $1,145,000 | 0.11% |